Sandra L Hatten - Net Worth and Insider Trading
Sandra L Hatten Net Worth
The estimated net worth of Sandra L Hatten is at least $752,120 dollars as of 2024-09-24. Sandra L Hatten is the See Remarks of Avadel Pharmaceuticals PLC and owns about 59,165 shares of Avadel Pharmaceuticals PLC (AVDL) stock worth over $751,987. Sandra L Hatten is also the Sr. VP, Quality of Mallinckrodt PLC and owns about 6,642 shares of Mallinckrodt PLC (MNKKQ) stock worth over $133. Details can be seen in Sandra L Hatten's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Sandra L Hatten has not made any transactions after 2019-12-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Sandra L Hatten
Sandra L Hatten Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Sandra L Hatten owns 3 companies in total, including Avadel Pharmaceuticals PLC (AVDL) , Mallinckrodt PLC (MNKKQ) , and Mallinckrodt PLC (MCKPF) .
Click here to see the complete history of Sandra L Hatten’s form 4 insider trades.
Insider Ownership Summary of Sandra L Hatten
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
AVDL | Avadel Pharmaceuticals PLC | 2019-12-12 | See Remarks |
MNKKQ | Mallinckrodt PLC | 2015-05-11 | Sr. Vice President Quality |
MCKPF | Mallinckrodt PLC | 2014-02-20 | Sr. Vice President Quality |
Sandra L Hatten Latest Holdings Summary
Sandra L Hatten currently owns a total of 2 stocks. Among these stocks, Sandra L Hatten owns 59,165 shares of Avadel Pharmaceuticals PLC (AVDL) as of December 12, 2019, with a value of $751,987 and a weighting of 99.98%. Sandra L Hatten also owns 6,642 shares of Mallinckrodt PLC (MNKKQ) as of May 11, 2015, with a value of $133 and a weighting of 0.02%.
Latest Holdings of Sandra L Hatten
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
AVDL | Avadel Pharmaceuticals PLC | 2019-12-12 | 59,165 | 12.71 | 751,987 |
MNKKQ | Mallinckrodt PLC | 2015-05-11 | 6,642 | 0.02 | 133 |
Holding Weightings of Sandra L Hatten
Sandra L Hatten Form 4 Trading Tracker
According to the SEC Form 4 filings, Sandra L Hatten has made a total of 1 transactions in Avadel Pharmaceuticals PLC (AVDL) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Avadel Pharmaceuticals PLC is the sale of 3,072 shares on December 12, 2019, which brought Sandra L Hatten around $22,211.
According to the SEC Form 4 filings, Sandra L Hatten has made a total of 0 transactions in Mallinckrodt PLC (MNKKQ) over the past 5 years. The most-recent trade in Mallinckrodt PLC is the sale of 2,024 shares on May 11, 2015, which brought Sandra L Hatten around $247,515.
Insider Trading History of Sandra L Hatten
- 1
Sandra L Hatten Trading Performance
GuruFocus tracks the stock performance after each of Sandra L Hatten's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Sandra L Hatten is -8.16%. GuruFocus also compares Sandra L Hatten's trading performance to market benchmark return within the same time period. The performance of stocks bought by Sandra L Hatten within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Sandra L Hatten's insider trading performs compared to the benchmark.
Performance of Sandra L Hatten
Sandra L Hatten Ownership Network
Sandra L Hatten Owned Company Details
What does Avadel Pharmaceuticals PLC do?
Who are the key executives at Avadel Pharmaceuticals PLC?
Sandra L Hatten is the See Remarks of Avadel Pharmaceuticals PLC. Other key executives at Avadel Pharmaceuticals PLC include Chief Financial Officer Thomas S Mchugh , director & Chief Executive Officer Greg J Divis , and Chief Commercial Officer Richard J Kim .
Avadel Pharmaceuticals PLC (AVDL) Insider Trades Summary
Over the past 18 months, Sandra L Hatten made no insider transaction in Avadel Pharmaceuticals PLC (AVDL). Other recent insider transactions involving Avadel Pharmaceuticals PLC (AVDL) include a net sale of 103,975 shares made by Mark Anthony Mccamish , a net purchase of 4,000 shares made by Thomas S Mchugh , and a net purchase of 14,000 shares made by Geoffrey Michael Glass .
In summary, during the past 3 months, insiders sold 0 shares of Avadel Pharmaceuticals PLC (AVDL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 103,975 shares of Avadel Pharmaceuticals PLC (AVDL) were sold and 43,500 shares were bought by its insiders, resulting in a net sale of 60,475 shares.
Avadel Pharmaceuticals PLC (AVDL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Avadel Pharmaceuticals PLC Insider Transactions
Sandra L Hatten Mailing Address
Above is the net worth, insider trading, and ownership report for Sandra L Hatten. You might contact Sandra L Hatten via mailing address: 10-1 Blanchardstown Corporate Park, Ballycoolin, Dublin L2 15.